Larvol Delta - EAP-Early-Access-Treatment-With-Tralesinidase-Alfa-in-Mucopolysaccharidosis-Type-IIIB-Sanfilippo-Syndrome-Type-B

lesinidase alfa (SBC-103) - AstraZeneca

tralesinidase alfa (AX 250) - Spruce Biosciences

http://clinicaltrials.gov/ct2/show/NCT07733856

Jul 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next